Extra PET scan to check for silent kidney transplant rejection
Part of Infections, Kidney & urinary clinical trials.
This study tests whether an additional PET scan can help detect and guide treatment for “subclinical” (silent) rejection in people with kidney transplants. It may help doctors spot problems earlier and manage them more appropriately.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be over 18 years old
- Have a kidney transplant (you are a kidney recipient)
- Not be pregnant
- Not have polyomavirus nephropathy
- Not be “highly sensitized,” meaning you have very strong past immune antibodies to donors
- Be able to continue corticosteroids (steroids should not be stopped)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how well a new blood test works to monitor kidney health after a transplant. It might help doctors catch problems early without needing a biopsy.
This study uses a special type of PET-CT scan (called FDG-PET) to see if it can better detect rejection in heart transplant patients. The goal is to find a less invasive way to check for rejection than the usual heart muscle biopsy.
This trial tests a new PET/CT scan that uses a special tracer to find clear cell kidney cancer. If you are scheduled for kidney tumor removal, this scan may help your surgeon see the cancer more clearly before surgery.
This trial tests a special PET scan that may help doctors predict how well your remaining kidney will work after part of it is removed. It could help guide surgery decisions and improve long-term outcomes.
This trial uses a special PET/CT scan to look at kidney scarring (fibrosis) in people with chronic kidney disease. It could help doctors monitor kidney damage without needing a biopsy.
This Phase 1 study tests whether a special PET/CT scan drug ([18F]PT2385) can help doctors see kidney cancer and related tumors. It may help guide diagnosis and treatment decisions, especially in people planning surgery or starting belzutifan.
Hear when a new Kidney Transplant Rejection trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.